You are here:Home
»
Molecular Biology
»
MB-Protein Kinase Inhibitors
»
HA1077 (Fasudil, 1-(5-Isoquinolinesulfonyl)-1H-hexahydro-1,4-diazepine•2HCl, 1-(5-Isoquinolinesulfonyl) Homopiperazine•2HCl)
HA1077 (Fasudil, 1-(5-Isoquinolinesulfonyl)-1H-hexahydro-1,4-diazepine•2HCl,
1-(5-Isoquinolinesulfonyl) Homopiperazine•2HCl)
Pricing
For pricing information, USA customers sign in. Outside USA? Please contact your distributor for pricing. Specifications
| The monohydrochloride salt is the form used to prepare formulations of this drug for clinical use. Note that the solubility properties of the mono- and di-HCl salts are different. Kinase inhibitor; has antivasospastic properties. | | | Catalog # | H1000-01 | | Solubility | Very soluble in water, up to 200mg/ml or more; soluble in DMSO up to about 10mg/ml; not soluble in ethanol; addition of an aqueous solution of this dihydrochloride salt into a buffer solution may significantly alter its solubility. | | Storage and Stability | May be stored at RT for short-term only. Long-term storage is recommended at -20°C. For maximum recovery of product, centrifuge the original vial prior to removing the cap. | | CAS Number | 103745-39-7 | | Molecular Formula | C14H17N3O2S•2HCl | | Molecular Weight | 364.29 | | Purity | ~99% | | Form | Supplied as a white to off-white powder. | | | Important Note | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological. | | Alternate names | HA-1077, Dihydrochloride Salt |
External Links
|
